The efficacy of rimegepant for the acute treatment of vestibular migraine
Abstract Introduction This study aimed to observe the efficacy and safety of rimegepant, a small-molecule calcitonin gene-related peptide (CGRP) receptor antagonist, for the acute treatment of vestibular migraine (VM). Methods Patients meeting the diagnostic criteria for VM or probable VM received r...
Na minha lista:
| Principais autores: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Portfolio
2026-02-01
|
| 叢編: | Scientific Reports |
| 主題: | |
| 在線閱讀: | https://doi.org/10.1038/s41598-026-39902-9 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|